Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
暂无分享,去创建一个
C. Liapis | N P E Kadoglou | T Gerasimidis | A Kapelouzou | A Moumtzouoglou | E D Avgerinos | J D Kakisis | P E Karayannacos | C D Liapis | T. Gerasimidis | J. Kakisis | E. Avgerinos | A. Moumtzouoglou | N. Kadoglou | A. Kapelouzou | P. Karayannacos
[1] William Insull,et al. Bilateral Symmetry of Human Carotid Artery Atherosclerosis , 2002, Stroke.
[2] C. Baracchini,et al. Progression of atherosclerosis in asymptomatic carotid arteries after contralateral endarterectomy: a 10-year prospective study. , 2007, Journal of vascular surgery.
[3] Mark Fisher,et al. Carotid Plaque Pathology: Thrombosis, Ulceration, and Stroke Pathogenesis , 2005, Stroke.
[4] P. Allan,et al. Fate of the non‐operated carotid artery after contralateral endarterectomy , 1995, The British journal of surgery.
[5] P. Rothwell,et al. Risk of Coronary and Other Nonstroke Vascular Death in Relation to the Presence and Extent of Atherosclerotic Disease at the Carotid Bifurcation , 2006, Stroke.
[6] Martin J Graves,et al. Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI , 2006, Stroke.
[7] R Eugene Zierler,et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. , 2003, Radiology.
[8] R. Vito,et al. Markers of inflammation collocate with increased wall stress in human coronary arterial plaque , 2009, Biomechanics and modeling in mechanobiology.
[9] M. Davidson,et al. A review of lipid management in primary and secondary prevention. , 2009, Journal of cardiopulmonary rehabilitation and prevention.
[10] Spyretta Golemati,et al. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. , 2008, Journal of vascular surgery.
[11] G. Sangiorgi,et al. Role of Inflammation in Atherosclerosis* , 2007, Journal of Nuclear Medicine.
[12] A. Arauz,et al. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography Pilot study , 2007, Clinical Neurology and Neurosurgery.
[13] Stefan Puchner,et al. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. , 2008, Radiology.
[14] W. Sheu,et al. The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases. , 2004, Atherosclerosis.
[15] W. Poewe,et al. Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease , 2004, Circulation.
[16] K. Yokote,et al. NK‐104, a 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells , 2001, British journal of pharmacology.
[17] D. Charlesworth,et al. Variability in measurement of internal carotid artery stenosis by arch angiography and duplex ultrasonography--time for a reappraisal? , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[18] C. Liapis,et al. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes. , 2009, Journal of diabetes and its complications.
[19] T. Rand,et al. Grading of Internal Carotid Artery Stenosis: Can CTA Overcome the Confusion? , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[20] A. Dahl,et al. Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability , 2008, Stroke.
[21] H. Weintraub,et al. Identifying the vulnerable patient with rupture-prone plaque. , 2008, The American journal of cardiology.
[22] J. Granada,et al. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] W. Insull. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. , 2009, The American journal of medicine.
[24] L. Liaw,et al. Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Golledge,et al. Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis , 2004, Stroke.
[26] A. Nicolaides,et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[27] B. Perler. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. , 2007, Seminars in vascular surgery.
[28] C. Liapis,et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[29] D. Mikhailidis,et al. Pleiotropic effects of statins--clinical evidence. , 2009, Current pharmaceutical design.
[30] M. Järvilehto,et al. Vasa vasorum hypoxia: initiation of atherosclerosis. , 2009, Medical hypotheses.
[31] M. Hori,et al. Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients. , 2008, Ultrasound in medicine & biology.
[32] B. Lal,et al. Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. , 2002, Journal of vascular surgery.